Molecules/BELANTAMAB MAFODOTIN

BELANTAMAB MAFODOTIN

Molecular Identity

Antibody drug conjugateApprovedFirst approved 2020

Mechanism of action: Tumor necrosis factor receptor superfamily member 17 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

BELANTAMAB MAFODOTINBELANTAMAB MAFODOTINABELANTAMAB MAFODOTIN BLMFBELANTAMAB MAFODOTIN-BLMFBELANTAMAB MAFODOTINEBlenrepGSK-2857916GSK2857916

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BELANTAMAB MAFODOTIN

Loading drug network...